Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 5.1K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

The use of propensity score methods with survival or time‐to‐event outcomes: reporting measures of effect similar to those used in randomized experiments

Peter C. Austin · Statistics in Medicine · 2013 · 1.4K citations · Full text

Public Health, Biostatistics, Causal Inference +15

Stroke Severity in Atrial Fibrillation

Huey‐Juan Lin, Philip A. Wolf, Margaret Kelly‐Hayes et al. · Stroke · 1996 · 1.4K citations

Medicine, Cardiology, Clinical Cardiology +15